Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

Core Viewpoint - Repligen Corporation will participate in the J.P. Morgan 2026 Healthcare Conference, highlighting its focus on bioprocessing technology leadership [1]. Group 1: Company Overview - Repligen Corporation is a global life sciences company that develops and commercializes innovative bioprocessing technologies and systems for manufacturing biological drugs [3]. - The company serves biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide [3]. - Key focus areas include Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins [3]. - The corporate headquarters is located in Waltham, Massachusetts, with manufacturing sites primarily in the U.S. and additional sites in Estonia, France, Germany, Ireland, the Netherlands, and Sweden [3]. Group 2: Conference Participation - Olivier Loeillot, President and CEO, will present an overview of the company on January 13 at 2:15 p.m. PT during the conference [1]. - A live webcast of the conference presentations will be available on Repligen's Investor Relations website, with a replay accessible for a limited time after the event [2].